A new report estimates that 135,987 babies will be born with HIV during the 90-day stoppage on foreign aid spending.

On Friday, a memorandum signed by Marco Rubio called for a 90-day cessation of foreign aid. That would likely put on hold the work of PEPFAR, the President's Emergency Plan for AIDS Relief.

The President's Emergency Plan for AIDS Relief, or PEPFAR, provides billions in funding to organizations to combat HIV.

The President's Emergency Plan for AIDS Relief has provided life-saving treatment to tens of millions since it was established in 2003

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via

The World Health Organisation (WHO) has warned of adverse consequences of the immediate suspension of funding for HIV programmes in Nigeria and other low- and middle-income countries under the United States President's Emergency Plan for AIDS Relief  (PEPFAR) - a flagship initiative of the global HIV response established over 20 years ago.

Secretary of State Marco Rubio’s order to pause nearly all foreign aid has halted funding to the President’s Emergency Plan for AIDS Relief (PEPFAR), an African HIV-prevention program launched by President George W. Bush in 2003 that has saved over 25 million lives.

JOHANNESBURG - More than 15,000 health workers in the country will be affected by the Trump administration’s decision to withdraw HIV/AIDS relief. Earlier this week, US President Donald Trump announced a freeze on the President’s Emergency Plan for AIDS Relief (PEPFAR).

A legally contested executive order on foreign aid did, at least initially, halt the distribution of life-saving HIV drugs.

The decision, made by US Secretary of State Marco Rubio, enables individuals in 55 countries, including South Africa, to receive uninterrupted access to US-funded HIV treatment, a crucial lifeline amidst swirling concerns regarding funding cuts.

PEPFAR, a $7.5 billion initiative established in 2003, has provided HIV care to millions worldwide. The recent suspension of the program raised concerns about the potential loss of access to HIV medications for more than 20 million people.